Commentary | Published:

Dendritic cells: versatile controllers of the immune system

Nature Medicine volume 13, pages 11551159 (2007) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).

  2. 2.

    & Regulation of T cell immunity by dendritic cells. Cell 106, 263–266 (2001).

  3. 3.

    Dendritic cells in immunity and tolerance—do they display opposite functions? Immunity 19, 5–8 (2003).

  4. 4.

    Variegation of the immune response with dendritic cells and pathogen recognition receptors. J. Immunol. 174, 2457–2465 (2005).

  5. 5.

    & Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23, 975–1028 (2005).

  6. 6.

    A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20, 67–69 (1957).

  7. 7.

    Genes and antibodies. Science 129, 1649–1653 (1959).

  8. 8.

    , , & A complete immunoglobulin gene is created by somatic recombination. Cell 15, 1–14 (1978).

  9. 9.

    et al. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu. Science 236, 816–819 (1987).

  10. 10.

    , , & Antigen in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles. J. Exp. Med. 127, 277–296 (1968).

  11. 11.

    & The immunogenicity of antigen bound to the plasma membrane of macrophages. J. Exp. Med. 131, 711–726 (1970).

  12. 12.

    The macrophage—versatile element of inflammation. In The Harvey Lectures 1981–1982, Series 77 63–80 (Academic Press, New York, 1983).

  13. 13.

    & The interaction of soluble horseradish peroxidase with mouse peritoneal macrophages in vitro. J. Cell Biol. 55, 186–204 (1972).

  14. 14.

    & The interaction of particulate horseradish peroxidase (HRP)-anti HRP immune complexes with mouse peritoneal macrophages in vitro. J. Cell Biol. 55, 616–634 (1972).

  15. 15.

    & Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126, 423–442 (1967).

  16. 16.

    A requirement for two cell types for antibody formation in vitro. Science 158, 1573–1575 (1967).

  17. 17.

    & Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142–1162 (1973).

  18. 18.

    & Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J. Exp. Med. 139, 380–397 (1974).

  19. 19.

    & Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75, 5132–5136 (1978).

  20. 20.

    , , & Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. J. Exp. Med. 152, 1070–1084 (1980).

  21. 21.

    , , & Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J. Exp. Med. 157, 613–627 (1983).

  22. 22.

    et al. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J. Exp. Med. 158, 174–191 (1983).

  23. 23.

    , , & Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and man. Proc. Natl. Acad. Sci. USA 80, 6041–6045 (1983).

  24. 24.

    & Protein-specific helper T lymphocyte formation initiated by dendritic cells. Science 229, 475–479 (1985).

  25. 25.

    & Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526–546 (1985).

  26. 26.

    et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169, 1169–1178 (1989).

  27. 27.

    Dendritic cells: from the fabric of immunology. Clin. Invest. Med. 27, 231–236 (2004).

  28. 28.

    Dendritic cells: understanding immunogenicity. Eur. J. Immunol. (in the press).

  29. 29.

    & Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701–702 (1974).

  30. 30.

    & H-2 compatibility is required for T-cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J. Exp. Med. 141, 502–507 (1975).

  31. 31.

    On the thymus in the differentiation of “H-2 self-recognition” by T cells: evidence for dual recognition? J. Exp. Med. 147, 882–896 (1978).

  32. 32.

    et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2, 361–367 (2001).

  33. 33.

    et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254–258 (2005).

  34. 34.

    , , & Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203, 2841–2852 (2006).

  35. 35.

    et al. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5, 1243–1250 (2004).

  36. 36.

    & Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4, 579–585 (2003).

  37. 37.

    , , & Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 200, 847–856 (2004).

  38. 38.

    et al. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction. Nature 440, 890–895 (2006).

  39. 39.

    et al. Stable T cell–dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat. Immunol. 6, 707–714 (2005).

  40. 40.

    et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769–780 (2001).

  41. 41.

    et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627–1638 (2002).

  42. 42.

    et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091–1097 (2002).

  43. 43.

    , , , & Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11, 748–756 (2005).

  44. 44.

    , , & Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22, 561–570 (2005).

  45. 45.

    et al. Intensified and protective CD4+ T cell immunity at a mucosal surface after a single dose of anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203, 607–617 (2006).

  46. 46.

    et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 24, 827–838 (2006).

  47. 47.

    , , , & Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233–238 (2001).

  48. 48.

    , , & Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18, 713–720 (2003).

  49. 49.

    et al. Dendritic cell–expanded, islet-specific, CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204, 191–201 (2007).

  50. 50.

    et al. Dendritic cells with TGF-β1 differentiate naive CD4+CD25 T cells into islet-protective Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104, 2821–2826 (2007).

  51. 51.

    et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527–538 (2004).

  52. 52.

    et al. A functionally specialized population of mucosal CD103+ DCs induce Foxp3+ regulatory T cells via a TGF-β− and retinoic acid–dependent mechanism. J. Exp. Med. 204, 1757–1764 (2007).

  53. 53.

    , , , & Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621–667 (2002).

  54. 54.

    et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo. J. Exp. Med. 204, 1095–1106 (2007).

  55. 55.

    et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107–111 (2007).

  56. 56.

    et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815–824 (2004).

  57. 57.

    et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc. Natl. Acad. Sci. USA 104, 1289–1294 (2007).

  58. 58.

    , & Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86–89 (1998).

  59. 59.

    et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126, 205–218 (2006).

  60. 60.

    Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476–483 (2006).

  61. 61.

    , & Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202, 203–207 (2005).

  62. 62.

    , , , & The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607–1618 (2004).

  63. 63.

    , , & CD103 and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 178, 6861–6866 (2007).

  64. 64.

    & TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9, 1245–1250 (2003).

  65. 65.

    et al. Increase in TNFα and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. USA 102, 19057–19062 (2005).

  66. 66.

    et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407–417 (2005).

  67. 67.

    et al. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487–496 (2007).

  68. 68.

    et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat. Immunol. 3, 673–680 (2002).

  69. 69.

    et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J. Exp. Med. 201, 627–636 (2005).

  70. 70.

    et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203, 599–606 (2006).

  71. 71.

    Immunotherapy: past, present and future. Nat. Med. 9, 269–277 (2003).

  72. 72.

    & Cancer immunotherapy: a treatment for the masses. Science 305, 200–205 (2004).

  73. 73.

    In Les Prix Nobel 1974 (ed. Odelberg, W.) 36–37 (Imprimerie Royale P.A. Norstedt & Söner, Stockholm, 1975)

Download references

Acknowledgements

I thank the jury of the Lasker Awards for selecting dendritic cells for the 2007 Lasker Award in Basic Medical Science. There are so many areas of progress in our profession that I am lucky and honored to work in a subject that has been deemed worthy of recognition by the Lasker Foundation. During my career, I have received help from many quarters. Z. Cohn was my vital mentor and colleague in the demanding early years of dendritic-cell research. The US National Institutes of Health and many foundations generously supported our research. The field of immunology has repeatedly provided the methods, findings and concepts that have been essential for our progress. The community of dendritic-cell biologists has beautifully unraveled the field that is celebrated this year. The Rockefeller University, my professional home for 37 years, has provided inspiring traditions in cell biology, immunology and patient-based research, as well as a fantastic community devoted to science for the benefit of humankind. My colleagues in and out of the lab have been exceptional for their commitment and insights. I am particularly indebted to C. Moberg for editorial help with manuscripts and to my senior colleagues M. Nussenzweig and J. Ravetch for continuing friendship and collaboration. My family has always inspired me with their special dispositions, talents and support.

Author information

Affiliations

  1. The author is at The Rockefeller University, 1230 York Avenue, New York, New York 10065-6399, USA. steinma@rockefeller.edu

    • Ralph M Steinman

Authors

  1. Search for Ralph M Steinman in:

Competing interests

The author is a scientific consultant to Celldex, which is developing vaccines based on delivery of antigens to dendritic cells.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm1643

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing